Omics Research Takes Aim at Advanced Cancers
A study led by Mayo Clinic researchers has identified a common epigenomic fingerprint and potential target for metastatic cancer therapies.
Read MoreSearch Results for: lung cancer
NGS Service Offers Competitive Price Point for Cancer Testing
With a turnaround time of less than 7 days per reportable result, a next-generation sequencing service will perform molecular panel testing for invasive colon cancer for under $1,000.
Read MoreFDA Grants PMA for Colorectal Cancer Mutation Test
A new molecular PCR test identifies KRAS mutations to aid in determining therapy for metastatic colorectal cancer.
Read More
Inside Track: Molecular Markers for Colorectal Cancer
CLP speaks with Antonia R. Sepulveda, MD, PhD, FASCP, FCAP, of Columbia University, about a forthcoming clinical practice guideline for the use of molecular marker testing in patients with primary or metastatic colorectal carcinoma.
Read More
March 2015 Product Spotlight: Cancer Diagnostics
Featured cancer diagnostics products include the Therascreen EGFR RGQ Plasma PCR kit from Qiagen, a KRAS screening multiplex kit from Bio-Rad Laboratories, and the Prostate Health Index from Beckman Coulter Diagnostics.
Read More